| Financial Year |
March 31 2023 |
| Monetary Funds |
310,714,825.29 |
| Held-for-trading Financial Assets |
120,669,238.42 |
| Notes Receivable |
-- |
| Accounts Receivable |
906,009,185.83 |
| Advances to Suppliers |
70,131,114.84 |
| Other Receivables |
28,877,938.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
69,746,326.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
360,000.01 |
| Other Current Assets |
12,585,021.25 |
| Total Current Assets |
1,718,192,740.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
954,000.00 |
| Long-term Equity Investment |
5,171,099.05 |
| Investment Properties |
25,408,055.57 |
| Fixed Assetes |
410,163,093.56 |
| Under-construction Projects |
114,215,453.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
66,744,603.87 |
| R&D expenses |
15,684,606.21 |
| Goodwill |
23,542,712.26 |
| Long-Term Deferred and Prepaid Expenses |
2,902,790.92 |
| Deferred Income Tax Assets |
50,100,088.70 |
| Other Non-Current Assets |
3,786,193.98 |
| Sub-Total of Non-Current Assets |
726,625,131.38 |
| Total Assets |
2,444,817,871.93 |
| Short-Term Loans |
401,719,359.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
148,658,968.18 |
| Accounts Payable |
440,381,321.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,444,136.88 |
| Taxes Payable |
28,303,408.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,163,204.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,757,303.00 |
| Other Current Liabilities |
1,297,864.14 |
| Sub-Total of Current Liabilities |
1,089,577,284.19 |
| Long-term Loans |
59,736,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,673,118.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
100,119,313.25 |
| Total Liabilities |
1,189,696,597.44 |
| Paid-In Capital(Or Share Stock) |
557,577,326.00 |
| Capital Surplus |
366,819,713.39 |
| Surplus Reserve |
35,042,643.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
293,447,883.32 |
| Minority Stockholder's Interest |
2,177,896.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,252,943,377.65 |
| Owner's Equity（Stockholder's Equity） |
1,255,121,274.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,444,817,871.93 |
